Cargando…

Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department

INTRODUCTION: The benefit of reducing the time of antibiotic initiation in the emergency department (ED) for neutropenic patients is controversial and the research on the impact of antibiotic adherence to international guidelines in the ED is scarce. We aimed to investigate the effect of antibiotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Peyrony, Olivier, Gerlier, Camille, Barla, Imola, Ellouze, Sami, Legay, Léa, Azoulay, Elie, Chevret, Sylvie, Fontaine, Jean-Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048306/
https://www.ncbi.nlm.nih.gov/pubmed/32109264
http://dx.doi.org/10.1371/journal.pone.0229828
_version_ 1783502276032200704
author Peyrony, Olivier
Gerlier, Camille
Barla, Imola
Ellouze, Sami
Legay, Léa
Azoulay, Elie
Chevret, Sylvie
Fontaine, Jean-Paul
author_facet Peyrony, Olivier
Gerlier, Camille
Barla, Imola
Ellouze, Sami
Legay, Léa
Azoulay, Elie
Chevret, Sylvie
Fontaine, Jean-Paul
author_sort Peyrony, Olivier
collection PubMed
description INTRODUCTION: The benefit of reducing the time of antibiotic initiation in the emergency department (ED) for neutropenic patients is controversial and the research on the impact of antibiotic adherence to international guidelines in the ED is scarce. We aimed to investigate the effect of antibiotic timing and appropriateness on outcomes in patients with febrile neutropenia (FN) and to assess the performance of the MASCC risk-index to risk-stratify such patients in the ED. METHODS: We prospectively identified patients with FN who presented to our ED and assessed their Multinational Association of Supportive Care in Cancer (MASCC) risk-index. The time to parenteral antibiotic initiation and the appropriateness of the antibiotic regimen according to international guidelines were retrospectively abstracted. The performance of the MASCC risk-index in predicting the absence of complication was assessed with sensitivity, specificity and the area under the receiver operating characteristics curve (AUC). We investigated the effect of the time to antibiotic initiation and the appropriateness of the antibiotic regimen on the outcome (ICU admission or death) by logistic regression analyses. RESULTS: We included 249 patients. Median age was 60 years and 67.9% had hematological malignancies, 26 (10.4%) were admitted to the ICU and 23 (9.8%) died during hospital stay. Among the 173 patients at low risk according to the MASCC risk-index, 56 (32.4%) presented at least one complication including 11 deaths. The MASCC risk-index had a sensitivity and a specificity of 0.78% and 0.43%, respectively, in predicting the absence of complication and the AUC was 0.67. The time to antibiotic initiation in the ED was not associated with the outcome after adjusting for performance status and shock-index. Conversely, an inadequate ED antibiotic regimen was associated with higher ICU admission or death during hospital stay (OR = 3.50; 95% CI = 1.49 to 8.28). CONCLUSION: An inadequate ED antibiotic regimen in patients with FN was significantly associated with higher ICU admission or death during hospital stay.
format Online
Article
Text
id pubmed-7048306
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-70483062020-03-09 Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department Peyrony, Olivier Gerlier, Camille Barla, Imola Ellouze, Sami Legay, Léa Azoulay, Elie Chevret, Sylvie Fontaine, Jean-Paul PLoS One Research Article INTRODUCTION: The benefit of reducing the time of antibiotic initiation in the emergency department (ED) for neutropenic patients is controversial and the research on the impact of antibiotic adherence to international guidelines in the ED is scarce. We aimed to investigate the effect of antibiotic timing and appropriateness on outcomes in patients with febrile neutropenia (FN) and to assess the performance of the MASCC risk-index to risk-stratify such patients in the ED. METHODS: We prospectively identified patients with FN who presented to our ED and assessed their Multinational Association of Supportive Care in Cancer (MASCC) risk-index. The time to parenteral antibiotic initiation and the appropriateness of the antibiotic regimen according to international guidelines were retrospectively abstracted. The performance of the MASCC risk-index in predicting the absence of complication was assessed with sensitivity, specificity and the area under the receiver operating characteristics curve (AUC). We investigated the effect of the time to antibiotic initiation and the appropriateness of the antibiotic regimen on the outcome (ICU admission or death) by logistic regression analyses. RESULTS: We included 249 patients. Median age was 60 years and 67.9% had hematological malignancies, 26 (10.4%) were admitted to the ICU and 23 (9.8%) died during hospital stay. Among the 173 patients at low risk according to the MASCC risk-index, 56 (32.4%) presented at least one complication including 11 deaths. The MASCC risk-index had a sensitivity and a specificity of 0.78% and 0.43%, respectively, in predicting the absence of complication and the AUC was 0.67. The time to antibiotic initiation in the ED was not associated with the outcome after adjusting for performance status and shock-index. Conversely, an inadequate ED antibiotic regimen was associated with higher ICU admission or death during hospital stay (OR = 3.50; 95% CI = 1.49 to 8.28). CONCLUSION: An inadequate ED antibiotic regimen in patients with FN was significantly associated with higher ICU admission or death during hospital stay. Public Library of Science 2020-02-28 /pmc/articles/PMC7048306/ /pubmed/32109264 http://dx.doi.org/10.1371/journal.pone.0229828 Text en © 2020 Peyrony et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Peyrony, Olivier
Gerlier, Camille
Barla, Imola
Ellouze, Sami
Legay, Léa
Azoulay, Elie
Chevret, Sylvie
Fontaine, Jean-Paul
Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department
title Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department
title_full Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department
title_fullStr Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department
title_full_unstemmed Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department
title_short Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department
title_sort antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048306/
https://www.ncbi.nlm.nih.gov/pubmed/32109264
http://dx.doi.org/10.1371/journal.pone.0229828
work_keys_str_mv AT peyronyolivier antibioticprescribingandoutcomesincancerpatientswithfebrileneutropeniaintheemergencydepartment
AT gerliercamille antibioticprescribingandoutcomesincancerpatientswithfebrileneutropeniaintheemergencydepartment
AT barlaimola antibioticprescribingandoutcomesincancerpatientswithfebrileneutropeniaintheemergencydepartment
AT ellouzesami antibioticprescribingandoutcomesincancerpatientswithfebrileneutropeniaintheemergencydepartment
AT legaylea antibioticprescribingandoutcomesincancerpatientswithfebrileneutropeniaintheemergencydepartment
AT azoulayelie antibioticprescribingandoutcomesincancerpatientswithfebrileneutropeniaintheemergencydepartment
AT chevretsylvie antibioticprescribingandoutcomesincancerpatientswithfebrileneutropeniaintheemergencydepartment
AT fontainejeanpaul antibioticprescribingandoutcomesincancerpatientswithfebrileneutropeniaintheemergencydepartment